• 12/01/2015

    PAION announces initiation of U.S. clinical safety trial of Remimazolam in high risk patients undergoing colonoscopy

  • 11/11/2015

    PAION AG reports results for the first nine months 2015

  • 10/27/2015

    Launch of new PAION Corporate Website

  • 10/14/2015

    PAION receives positive feedback from Japanese authority PMDA about production of Remimazolam for Japan

  • 10/12/2015

    Remimazolam posters at Anesthesiology® 2015

  • 08/27/2015

    Juergen Raths, MD appointed as Chief Operating Officer at PAION AG

  • 08/12/2015

    PAION AG reports financial results for the first half-year of 2015

  • 08/11/2015

    PAION starts EU Phase III study with Remimazolam in the indication general anesthesia

  • 08/07/2015

    Timothy E. Morris joins PAION, Inc. as a non-executive Director

  • 07/23/2015

    PAION completed Remimazolam know-how and tech transfer from Ono

  • 07/07/2015

    Dr. Mariola Söhngen will leave management board of PAION AG as of 31 October 2015 and PAION plans new composition of executive management

  • 06/08/2015

    PAION announces initiation of second U.S. Phase III clinical trial of Remimazolam for procedural sedation during bronchoscopy

  • 05/13/2015

    Q1 2015: Earnings call and webcast (in English) on 13 May 2015

  • 05/13/2015

    PAION AG reports financial results for the first quarter 2015

  • 05/07/2015

    David Bernstein, M.D. joins PAION as medical advisor

  • 03/31/2015

    PAION announces initiation of U.S. Phase III clinical trial of Remimazolam for procedural sedation during colonoscopy

  • 03/18/2015

    PAION AG reports financial results for the full year 2014